Middle East & Africa ELISA Diagnostics Tests Market Forecast to 2030 - Regional Analysis - by Adoption, Test Type, Application, and End User

Description

List of Tables

The Middle East & Africa ELISA diagnostics tests market was valued at US$ 67.74 million in 2022 and is expected to reach US$ 94.26 million by 2030; it is estimated to grow at a CAGR of 4.2% from 2022 to 2030.

Advancements in ELISA-Based Procedures Boost Middle East & Africa ELISA Diagnostics Tests Market

The use of ELISA for in-vitro diagnostics (IVD) has gained considerable attention in the global market. Researchers from various fields have been attracted to the development and application of ELISA-based procedures through techniques such as magnetic beads, paper-based platforms, and nanomaterials. Other examples of technology-based ELISA kits are digital ELISA, Multiplex ELISA, Single-Molecule ELISA, Nanoparticle-Based ELISA, and Smartphone-Based ELISA. Also, companies launch ELISA testing kits based on several techniques for fast and efficient clinical results. The "AMP'D ELISA Signal Amplification system" is manufactured by Enzo Life Sciences, Inc. The AMP'D Technology efficiently improves the sensitivity of sandwich ELISA test type with a single amplification kit and offers high sensitivity.

Cell Signaling Technology, Inc.'s "PathScan Phospho-RSK1 (Ser380) Sandwich ELISA Kit," designed by Cell Signaling Technology, is another example of a technology-advanced ELISA test kit product. Such advanced technology-based ELISA test kit products will have a high demand in the future by veterinarian for the detection of different species responsible for veterinary and human-associated infections or diseases. Therefore, advancements in ELISA-based procedures are expected to bolster the ELISA diagnostic test market growth during 2020-2030. ELISA diagnostic test.

Middle East & Africa ELISA Diagnostics Tests Market Overview

There is a high prevalence of Tomato yellow leaf curl virus (TYLCV) belonging to the genus begomovirus of the family Geminiviridae. The TYLCV causes serious damage to tomato plants with up to 96.9% yield loss and quality reduction with transmission through whitefly and mechanically from infected tomatoes to different species such as Amarnthaceae, Chenopodiaceae, Cruciferae, Cucurbitaceae, Leguminaceae (Fabaceae), Malvaceae, and Solanaceae. To control the transmission of TYLCV to the Saudi population, the ELISA test is in high demand among the population and diagnostic laboratories.

Additionally, cases of hepatitis C virus (HCV) infection are rising among the Saudi population. The average prevalence rate of HBsAg is 7% in the Kingdom of Saudi Arabia (KSA). Therefore, the government adopted a policy to integrate hepatitis B vaccination and extend the program of immunization. Also, with the rising prevalence of HCV, diagnostic testing has increased by testing through the ELISA system. Therefore, rising HCV and TYLCV infection cases among the Saudi population propel the demand for ELISA systems.

Middle East & Africa ELISA Diagnostics Tests Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa ELISA Diagnostics Tests Market Segmentation

The Middle East & Africa ELISA diagnostics tests market is segmented based on adoption, test type, application, end user, and country. Based on adoption, the Middle East & Africa ELISA diagnostics tests market is bifurcated into human and veterinary. The human segment held a larger market share in 2022.

In terms of test type, the Middle East & Africa ELISA diagnostics tests market is segmented into sandwich ELISA, indirect ELISA, competitive ELISA, and multiple & portable ELISA. The indirect ELISA segment held the largest market share in 2022.

Based on application, the Middle East & Africa ELISA diagnostics tests market is segmented into autoimmune diseases, infectious diseases, cancer diagnosis, protein quantification, and others. The infectious diseases segment held the largest market share in 2022.

By end user, the Middle East & Africa ELISA diagnostics tests market is segmented into hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospitals & diagnostic laboratories, and others. The hospitals & diagnostic centers segment held the largest market share in 2022.

Based on country, the Middle East & Africa ELISA diagnostics tests market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa ELISA diagnostics tests market share in 2022.

Bio-Rad Laboratories Inc., Idexx Laboratories Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corp., DiaSorin SpA, and Elabscience Biotechnology Inc. are some of the leading companies operating in the Middle East & Africa ELISA diagnostics tests market.

Product Code: BMIRE00029817

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
- 1.2.1 Middle East & Africa ELISA Diagnostic Tests Market - by Adoption
- 1.2.2 Middle East & Africa ELISA Diagnostic Tests Market - by Test Type
- 1.2.3 Middle East & Africa ELISA Diagnostic Tests Market - by Application
- 1.2.4 Middle East & Africa ELISA Diagnostic Tests Market - by End User
- 1.2.5 Middle East & Africa ELISA Diagnostic Tests Market - by Country

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Middle East & Africa ELISA Diagnostic Test Market - Key Industry Dynamics

4.1 Key Market Drivers
- 4.1.1 Rising Infectious Diseases Among Animals
- 4.1.2 Increasing Incidence of Human Infections
4.2 Key Market Restraints
- 4.2.1 Incidents of Product Recalls
4.3 Key Market Opportunities
- 4.3.1 Innovative Product Launches
4.4 Future Trends
- 4.4.1 Advancements in ELISA-Based Procedures

5. ELISA Diagnostic Tests Market - Middle East & Africa Market Analysis

5.1 Overview
5.2 Middle East & Africa ELISA Diagnostic Tests Market Revenue (US$ Mn), 2022 - 2030

6. Middle East & Africa ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Adoption

6.1 Overview
6.2 ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
6.3 Human
- 6.3.1 Overview
- 6.3.2 Human: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Veterinary
- 6.4.1 Overview
- 6.4.2 Veterinary: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

7. Middle East & Africa ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Test Type

7.1 Overview
7.2 ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
7.3 Sandwich ELISA
- 7.3.1 Overview
- 7.3.2 Sandwich ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Indirect ELISA
- 7.4.1 Overview
- 7.4.2 Indirect ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Competitive ELISA
- 7.5.1 Overview
- 7.5.2 Competitive ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Multiple & Portable ELISA
- 7.6.1 Overview
- 7.6.2 Multiple & Portable ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

8. Middle East & Africa ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Application

8.1 Overview
8.2 Middle East & Africa ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Autoimmune Diseases
- 8.3.1 Overview
- 8.3.2 Autoimmune Diseases: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Infectious Disease
- 8.4.1 Overview
- 8.4.2 Infectious Disease: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Cancer Diagnosis
- 8.5.1 Overview
- 8.5.2 Cancer Diagnosis: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Protein Quantification
- 8.6.1 Overview
- 8.6.2 Protein Quantification: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

9. Middle East & Africa ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 Middle East & Africa ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals & Diagnostic Centers
- 9.3.1 Overview
- 9.3.2 Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Pharmaceutical & Biotechnology Companies
- 9.4.1 Overview
- 9.4.2 Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Veterinary Hospitals & Diagnostic Laboratories
- 9.5.1 Overview
- 9.5.2 Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

10. Middle East & Africa ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - Country Analysis

10.1 Middle East & Africa: ELISA Diagnostic Tests Market
- 10.1.1 Middle East & Africa: ELISA Diagnostic Tests Market, by Country
  - 10.1.1.1 South Africa: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 South Africa: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.3 South Africa: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 10.1.1.1.4 South Africa: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 10.1.1.1.5 South Africa: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.1.6 South Africa: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.2 Saudi Arabia: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Saudi Arabia: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.3 Saudi Arabia: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 10.1.1.2.4 Saudi Arabia: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 10.1.1.2.5 Saudi Arabia: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.2.6 Saudi Arabia: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.3 UAE: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 UAE: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.3 UAE: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 10.1.1.3.4 UAE: ELISA Diagnostic Tests Market, by Test Type , 2020-2030 (US$ Million)
    - 10.1.1.3.5 UAE: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.3.6 UAE: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.4 Rest of Middle East & Africa: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.1 Overview
    - 10.1.1.4.2 Rest of Middle East & Africa: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.3 Rest of Middle East & Africa: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 10.1.1.4.4 Rest of Middle East & Africa: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 10.1.1.4.5 Rest of Middle East & Africa: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.4.6 Rest of Middle East & Africa: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)

11. ELISA Diagnostics Test Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in ELISA diagnostics test Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Bio-Rad Laboratories Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Idexx Laboratories Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 F. Hoffmann-La Roche Ltd
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Abbott Laboratories
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Danaher Corp
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 DiaSorin SpA
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Elabscience Biotechnology Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Financial Overview
- 12.8.4 SWOT Analysis
- 12.8.5 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms